Exceptional good distribution practice (GDP) flexibilities for medicines during the coronavirus (COVID-19) outbreak

The MHRA has published this list of temporary regulatory flexibilities; such as medicines may be returned to saleable stock if returned from wholesale distribution chain within 10 days & non-temperature-controlled transport may be used when ambient temperature is < 20°C.


Medicines and Healthcare products Regulatory Agency